444 related articles for article (PubMed ID: 34696267)
1. The Role of B-Cells and Antibodies against
Shukla M; Chandley P; Rohatgi S
Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696267
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with Secreted Aspartyl Proteinase 2 Protein from
Shukla M; Rohatgi S
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of immunoglobulin G antibodies against Candida enolase and fructose-bisphosphate aldolase for candidemia.
Li FQ; Ma CF; Shi LN; Lu JF; Wang Y; Huang M; Kong QQ
BMC Infect Dis; 2013 May; 13():253. PubMed ID: 23725337
[TBL] [Abstract][Full Text] [Related]
4. Protective antigens and mechanisms of anti-Candida immunity.
Antonio C
Nihon Ishinkin Gakkai Zasshi; 2000; 41(4):219. PubMed ID: 11064318
[TBL] [Abstract][Full Text] [Related]
5. Antibodies targeting
Singh S; Nabeela S; Barbarino A; Ibrahim AS; Uppuluri P
Front Immunol; 2022; 13():925821. PubMed ID: 35935947
[TBL] [Abstract][Full Text] [Related]
6. Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.
Xin H; Cutler JE
Clin Vaccine Immunol; 2011 Oct; 18(10):1656-67. PubMed ID: 21832099
[TBL] [Abstract][Full Text] [Related]
7. Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses.
Pitarch A; Jiménez A; Nombela C; Gil C
Mol Cell Proteomics; 2006 Jan; 5(1):79-96. PubMed ID: 16195222
[TBL] [Abstract][Full Text] [Related]
8. Moonlighting proteins induce protection in a mouse model against Candida species.
Medrano-Díaz CL; Vega-González A; Ruiz-Baca E; Moreno A; Cuéllar-Cruz M
Microb Pathog; 2018 Nov; 124():21-29. PubMed ID: 30118801
[TBL] [Abstract][Full Text] [Related]
9. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
[TBL] [Abstract][Full Text] [Related]
10. Potential of anti-Candida antibodies in immunoprophylaxis.
Cabezas J; Albaina O; Montañez D; Sevilla MJ; Moragues MD; Pontón J
Immunotherapy; 2010 Mar; 2(2):171-83. PubMed ID: 20635926
[TBL] [Abstract][Full Text] [Related]
11. Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence.
Torosantucci A; Chiani P; Bromuro C; De Bernardis F; Palma AS; Liu Y; Mignogna G; Maras B; Colone M; Stringaro A; Zamboni S; Feizi T; Cassone A
PLoS One; 2009; 4(4):e5392. PubMed ID: 19399183
[TBL] [Abstract][Full Text] [Related]
12. Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis.
Xin H; Dziadek S; Bundle DR; Cutler JE
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13526-31. PubMed ID: 18725625
[TBL] [Abstract][Full Text] [Related]
13. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.
Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A
Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271
[TBL] [Abstract][Full Text] [Related]
14. Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies.
Magliani W; Conti S; Giovati L; Maffei DL; Polonelli L
Front Biosci; 2008 May; 13():6920-37. PubMed ID: 18508705
[TBL] [Abstract][Full Text] [Related]
15. Humoral immune responses to Candida albicans complement receptor 3-related protein in the atopic subjects with vulvovaginal candidiasis. Novel sensitive marker for Candida infection.
Paulovičová E; Bujdáková H; Chupáčová J; Paulovičová L; Kertys P; Hrubiško M
FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25673750
[TBL] [Abstract][Full Text] [Related]
16. A novel Candida albicans Als3, Hwp1 and Met6 derived complex peptide protects mice against hematogenously induced candidiasis.
Diez A; Arrieta-Aguirre I; Carrano G; Fernandez-de-Larrinoa I; Moragues MD
Vaccine; 2024 May; ():. PubMed ID: 38789371
[TBL] [Abstract][Full Text] [Related]
17. Candida antigens and immune responses: implications for a vaccine.
Moragues MD; Rementeria A; Sevilla MJ; Eraso E; Quindos G
Expert Rev Vaccines; 2014 Aug; 13(8):1001-12. PubMed ID: 24957934
[TBL] [Abstract][Full Text] [Related]
18. Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis.
Xin H; Glee P; Adams A; Mohiuddin F; Eberle K
Vaccine; 2019 Apr; 37(18):2430-2438. PubMed ID: 30930005
[TBL] [Abstract][Full Text] [Related]
19. Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice.
Wang Y; Su Q; Dong S; Shi H; Gao X; Wang L
Hum Vaccin Immunother; 2014; 10(4):1057-63. PubMed ID: 24448202
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1.
Laín A; Elguezabal N; Brena S; García-Ruiz JC; Del Palacio A; Moragues MD; Pontón J
BMC Microbiol; 2007 Apr; 7():35. PubMed ID: 17448251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]